Ocean Spray partners with Canomiks to test and certify biological efficacy of cranberry

The relationship with Canomiks, through Ocean Spray’s existing partnership with the incubator Plug and Play, enables the company to further validate the superfruit nature of cranberry.

Ocean Spray Cranberries Inc. (Boston, MA) is partnering with Canomiks, leveraging its A.I.-based technology platform to test and certify the biological efficacy of cranberry. The relationship with Canomiks, through Ocean Spray’s existing partnership with the incubator Plug and Play, enables the company to further validate the superfruit nature of cranberry. Canomiks used its genomics, bioinformatics, and A.I.-based technology to test the bioactive components of cranberry called polyphenols to demonstrate their positive influence on genomic pathways responsible for modulating blood pressure and blood flow. Ocean Spray provided the concentrate and fruit extracts. Canomiks’ tests validate the results of previous clinical trials and builds upon Ocean Spray’s recent collaboration with Brightseed.

“This is an exciting initiative from our Emerging Science team intended to accelerate discovery research and study the benefits of bioactive compounds in the cranberries, supporting our belief that food is medicine and consuming a diet rich in plant bioactives, such as those found in cranberries, can help support health including benefitting heart health,” said Katy Galle, senior vice president of research & development at Ocean Spray Cranberries, Inc. in a press release.

“The area of food as medicine has been explored for many years and this research is principal in taking a step forward to making it a reality and inform future innovation from Ocean Spray,” said Leena Pradhan-Nabzdyk, PhD, CEO and co-founder of Canomiks.“We are thrilled to